Back to search

Article

Use of CD122+ natural killer cell precursors for superior anti-leukemia responses

2022-10-24

Abstract excerpt

Acute Myeloid Leukemia (AML) is an aggressive blood cancer in adults. Intensive induction therapy successfully induces a complete response in up to 80% of the adult patients but a fraction of them is refractory or relapses. The fraction of non-responsive or relapsing patients is especially high amongst medically unfit and older patients, who cannot undergo aggressive chemotherapy treatment. Therefore, offering pat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e61eea87-8c64-5568-b6ba-d5e18a40f231
DOI
10.1101/2022.10.24.513585
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Use of CD122+ natural killer cell precursors for superior anti-leukemia responsesDOI 10.1101/2022.10.24.513585
Select a neighboring publication to make it the new centre.